InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Montecalvo Antonio S., Directeur. Insider active across 1 company, notably Organogenesis Holdings Inc.. Cumulatively, 14 reports have been published. Split: 0 buy · 1 sell. Total volume traded: €78k. Activity tracked since 15 February 2022. The latest transaction was filed on 18 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Montecalvo Antonio S.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
11,330 shares0Class A Common StockSEC:0002064832-26-000092:0
40,625 shares0Class A Common StockSEC:0002064832-26-000053:0
1,389 shares@ US$3.732.8% of flowClass A Common StockSEC:0002064832-26-000025:0
42,493 shares0Class A Common StockSEC:0001062993-25-003231:0
3,453 shares@ US$3.708.1% of flowClass A Common StockSEC:0001062993-25-002939:0
1,752 shares@ US$2.803.0% of flowClass A Common StockSEC:0001062993-24-007932:0
43,732 shares0Class A Common StockSEC:0001062993-24-004315:0
8,657 shares@ US$3.6819.6% of flowClass A Common StockSEC:0001062993-24-003767:0
2,097 shares@ US$2.132.7% of flowClass A Common StockSEC:0001062993-23-008510:0
99,428 shares0Class A Common StockSEC:0001062993-23-004892:0
1,249 shares@ US$2.922.2% of flowClass A Common StockSEC:0001062993-23-004061:0
2,738 shares@ US$7.890.0030% mcap20.0% of flowClass A Common StockSEC:0001062993-22-009813:0
10,000 shares@ US$8.520.012% mcap80.0% of flowClass A Common StockSEC:0001062993-22-007530:0
14,383 shares0Class A Common StockSEC:0001062993-22-004804:0
14 of 14 declarations
About Montecalvo Antonio S.
Antonio S. Montecalvo is VP of Health Policy & Contracting at Organogenesis Holdings Inc. In this role, he is responsible for health strategy and contract management. His expertise in the healthcare field is crucial for developing innovative solutions.
